Can virtual group visits tame diabetes and heart risks?

NCT ID NCT06094491

Disease control Sponsor: University of Chicago Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 09, 2026 · Updated 3 times

Summary

This study tests whether virtual group visits—where patients meet online for diabetes education, support, and goal setting—can improve blood sugar control in people with type 2 diabetes who also have heart-related conditions. About 720 adults from participating clinics will take part. The main goal is to see if A1c levels drop, with additional checks on blood pressure, weight, and cholesterol.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance: Virtual group visits with diabetes education, social support, and goal setting
What this could lead to: If successful, this could offer a scalable way to help people with type 2 diabetes better manage their condition and reduce heart disease risks.
What could go wrong: This is a mid-stage trial, and virtual group visits may not work for everyone. Results depend on patient engagement and may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 720 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2024

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient at a PARTICIPATING clinic (at least one visit in year prior to first GV) * Type 2 diabetes * ≥ 18 years old * A1C\>8% within 6 months prior to first GV (we will first recruit patients with A1C\>9%, then if spaces still available A1C\>8.5%, then if spaces still available A1C\>8%) * At least one additional cardiovascular condition (hypertension, heart disease, stroke, hyperlipidemia, peripheral vascular disease, or BMI ≥ 30) * English or Spanish speaking * PCP assented to recruiting patient * Patient provides written consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Heart disease chronic are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

heart disorder hyperlipidemia hypertensive disorder Obesity obesity disorder peripheral vascular disease stroke disorder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Heart disease chronic Hyperlipidemias Hypertension Obesity Peripheral vascular diseases Stroke T2DM (type 2 diabetes mellitus)

Can virtual group visits tame diabetes and heart risks?

What the study statuses mean